Malaria resulting from infection by Plasmodium malariae.
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding Plasmodium malariae malaria can be attributed to its relative rarity compared to other malaria types, which affects the volume of systematic clinical studies. Additionally, the clinical features have not been thoroughly characterized, making it challenging to gather comprehensive data. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
There are several orphan drugs that have been designated for the treatment of Plasmodium malariae malaria, including artesunate, quinine sulfate, and tafenoquine. Additionally, there are drugs in development, though specific details about their phases are not available. As there are no active clinical trials currently reported, patients may want to stay informed about future research opportunities. For more information on clinical trials, you can search ClinicalTrials.gov for updates.
Actionable guidance for navigating care for Plasmodium malariae malaria
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding Plasmodium malariae malaria can be attributed to its relative rarity compared to other malaria types, which affects the volume of systematic clinical studies. Additionally, the clinical features have not been thoroughly characterized, making it challenging to gather comprehensive data. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
There are several orphan drugs that have been designated for the treatment of Plasmodium malariae malaria, including artesunate, quinine sulfate, and tafenoquine. Additionally, there are drugs in development, though specific details about their phases are not available. As there are no active clinical trials currently reported, patients may want to stay informed about future research opportunities. For more information on clinical trials, you can search ClinicalTrials.gov for updates.
Actionable guidance for navigating care for Plasmodium malariae malaria
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding Plasmodium malariae malaria can be attributed to its relative rarity compared to other malaria types, which affects the volume of systematic clinical studies. Additionally, the clinical features have not been thoroughly characterized, making it challenging to gather comprehensive data. This situation can be frustrating, but ongoing research may provide more insights in the future.
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
There are several orphan drugs that have been designated for the treatment of Plasmodium malariae malaria, including artesunate, quinine sulfate, and tafenoquine. Additionally, there are drugs in development, though specific details about their phases are not available. As there are no active clinical trials currently reported, patients may want to stay informed about future research opportunities. For more information on clinical trials, you can search ClinicalTrials.gov for updates.
Actionable guidance for navigating care for Plasmodium malariae malaria
To navigate your care for Plasmodium malariae malaria, consider consulting with an infectious disease specialist who has experience in malaria treatment. While there are no specific patient organizations identified for this condition, you can find resources through the National Organization for Rare Disorders (NORD) at rarediseases.org. Additionally, participating in research studies or registries could provide valuable insights into your condition. For genetic counseling, the National Society of Genetic Counselors maintains a directory at findageneticcounselor.com, which may be helpful if genetic factors are suspected in your case.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.